Aml Research

Feasibility Studies

Clinical trials often face delays in start up and patient recruitment. A well executed feasibility assessment can help to overcome these by providing information of the specific challenges your clinical trial might face. Risks can be mitigated to prevent or minimize delays. We ensure your trial gets off to the right start.

A comprehensive feasibility assessment includes:

  • Compatibility checks on protocol/clinical study plan and set-up with local healthcare services (personnel, equipment, ...)
  • Availability of patient population and patient willingness for participation
  • Assessing participation interest at research site level
  • Checks for impact of any ongoing competitive trials
  • Assessing Investigator grant requirements
  • Regulatory requirements and approval timelines

Each feasibility study will be tailored to the clinical trial.

AML has the expertise to assess clinical trial feasibility within Belgium, The Netherlands and Luxembourg and has an extensive database of potential investigator in many therapeutic areas.